These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1394347)

  • 1. Is regression of atherosclerosis possible?
    Hugenholtz PG; de Feyter PJ
    Cardiologia; 1992 Jun; 37(6):393-401. PubMed ID: 1394347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiographic regression of coronary atheromatosis].
    Szamosi A
    Lakartidningen; 1991 Apr; 88(15):1365-7. PubMed ID: 2020234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regression and therapy of atherosclerosis: regression of atherosclerosis under anti-cholesterol therapy].
    Yamamoto A
    Nihon Rinsho; 1988 Mar; 46(3):686-93. PubMed ID: 3404696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure.
    Schwabedal PE; Brügging-Schmitz G; Oestreich W; Szathmary SC
    J Hypertens Suppl; 1989 Dec; 7(6):S280-1. PubMed ID: 2632726
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regression of human coronary atherosclerosis. Mechanisms and clinical implications].
    da Luz PL; Solimene MC; Pileggi F
    Arq Bras Cardiol; 1995 Jan; 64(1):1-6. PubMed ID: 7669003
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regression of coronary arteriosclerosis with hypolipidemic treatment, myth or reality?].
    Lahoz C; Monereo A; Mostaza JM; de Oya M
    Rev Clin Esp; 1992 Nov; 191(7):380-4. PubMed ID: 1475466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of olivomycin on the spontaneous regression of experimental atherosclerosis in rabbits of different ages].
    Frol'kis VV; Novikova SM; Bohats'ka LN; Potapenko RI; Mozzhukhina TH; Kul'chyts'kyĭ OK; Burchyns'ka MK; Kopylova HV
    Fiziol Zh (1994); 1997; 43(3-4):3-10. PubMed ID: 9303799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L
    Acta Radiol Suppl; 1994; 392():1-27. PubMed ID: 8184697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular pharmacology (XII). Pharmacologic interventions in the progression of coronary atherosclerosis].
    Rayo Llerena I; Marín Huerta E
    Rev Esp Cardiol; 1995 May; 48(5):341-58. PubMed ID: 7792429
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of platelet-inhibiting drugs in models of atherosclerosis.
    Saunders RN
    Annu Rev Pharmacol Toxicol; 1982; 22():279-95. PubMed ID: 7044286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regression and therapy of atherosclerosis: regression of treated atherosclerosis viewed by coronary angiography].
    Nishimura S; Nakanishi S; Nishiyama S; Seki A; Yamaguchi H
    Nihon Rinsho; 1988 Mar; 46(3):679-85. PubMed ID: 3404695
    [No Abstract]   [Full Text] [Related]  

  • 15. [New prospects for the treatment of atherosclerosis: garlic preparations].
    Orekhov AN
    Ter Arkh; 1998; 70(8):75-8. PubMed ID: 9770756
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiographic progression and regression of coronary atherosclerosis].
    Nakanishi S; Seki A; Iwase T; Kato K
    Nihon Ronen Igakkai Zasshi; 1990 Jul; 27(4):416-8. PubMed ID: 2232310
    [No Abstract]   [Full Text] [Related]  

  • 17. The incidence of asymptomatic extracoronary atherosclerosis in patients with coronary atherosclerosis.
    Ciccone M; Di Noia D; Di Michele L; Corriero F; Di Biase M; Biasco MG; Novo S; Strano A; Rizzon P
    Int Angiol; 1993 Mar; 12(1):25-8. PubMed ID: 8376907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?].
    Møller K; Skinhøj P
    Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms underlying reduction of clinical events in lipid lowering trials.
    Mancini GB
    Can J Cardiol; 1995 May; 11 Suppl C():15C-17C. PubMed ID: 7750043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of atherosclerosis.
    Krupski WC
    Ann Vasc Surg; 1994 May; 8(3):303-17. PubMed ID: 8043366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.